DeGroot L J, Mayor G
Department of Medicine, University of Chicago, IL 60637.
Am J Med. 1992 Nov;93(5):558-64. doi: 10.1016/0002-9343(92)90585-y.
To determine the incidence of unrecognized thyroid disease among admissions to a large acute care university teaching hospital, 364 samples taken on consecutive admissions were assayed for thyroid-stimulating hormone (TSH) and free thyroxine index (FTI). Patients with abnormal test results were further evaluated by determination of antimicrosomal and antithyroglobulin antibodies, and charts were reviewed for evidence of prior diagnosis of thyroid disease, especially severe illness, drug treatment that might affect thyroid function tests, and prior diagnosis of thyroid disease. Results of subsequent thyroid function tests performed during the patient's hospitalization were correlated with the admission serum assays, and data on subsequent testing during the following 6 months were also obtained. A total of 3.9% of patients had significantly depressed TSH, and 11.1% of values were significantly elevated. A total of 11.3% of patients had significantly low FTI values, and 1% had significantly elevated values. A total of 7.4% appeared to have the euthyroid sick syndrome, 5.8% appeared to have unrecognized or undertreated primary thyroid failure, 6% had apparent subclinical hypothyroidism, 2% were thyrotoxic, and 2.8% (all women) had suppressed TSH levels for inapparent reasons. Limiting testing to patients over 49 years of age, or to women, would have missed many individuals with abnormal test results. Considering widespread availability of tests, relative costs, and value of the information obtained, it is suggested that the FTI determination would provide an appropriate screening test for patients in a population such as this entering a large, acute care general hospital.
为了确定一所大型急性护理大学教学医院入院患者中未被识别的甲状腺疾病的发病率,对连续入院患者采集的364份样本进行促甲状腺激素(TSH)和游离甲状腺素指数(FTI)检测。检测结果异常的患者进一步检测抗微粒体抗体和抗甲状腺球蛋白抗体,并查阅病历以寻找甲状腺疾病既往诊断的证据,尤其是严重疾病、可能影响甲状腺功能检测的药物治疗以及甲状腺疾病既往诊断。将患者住院期间后续进行的甲状腺功能检测结果与入院时的血清检测结果进行关联,并获取接下来6个月内后续检测的数据。共有3.9%的患者TSH显著降低,11.1%的值显著升高。共有11.3%的患者FTI值显著降低,1%的值显著升高。共有7.4%的患者似乎患有正常甲状腺病态综合征,5.8%的患者似乎患有未被识别或治疗不足的原发性甲状腺功能减退,6%的患者有明显的亚临床甲状腺功能减退,2%的患者甲状腺毒症,2.8%(均为女性)TSH水平因不明原因受到抑制。将检测限于49岁以上患者或女性,会遗漏许多检测结果异常的个体。考虑到检测的广泛可及性、相对成本以及所获信息的价值,建议FTI检测可为进入此类大型急性护理综合医院的患者提供合适的筛查检测。